课题基金 / 基金详情

项目摘要

项目成果

MARCELO JACOBS-LORENA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):世界上大约46%的人口生活在疟疾、丝虫病、病毒性脑炎、登革热和黄热病等蚊媒疾病流行的地区。最近发现,在城市环境中,昆虫病原真菌绿僵菌(Metarhizium anisopliae)具有控制成蚊的潜力,但前提是增强其效力。我们的目标是生产一种或多种真菌产品,这些产品可以消耗疟蚊和疟原虫种群,从而显著降低疟疾流行率。我们已经证明,绿僵菌是一种非常有效的昆虫选择性蝎子毒素ait的传递系统,表达ait可以使对蚊子的有效孢子剂量减少9倍。这是非常重要的,但杀戮时间仍然太慢,不足以提供足够的保护。在这个应用中,我们提出了实验来比较优化绿僵菌抑制疾病传播能力的几种策略。感染真菌的蚊子在唾液腺上的孢子虫数量显著减少,但其机制尚不清楚。我们将对疟原虫、蚊子和绿僵菌之间的相互作用进行详细的分析。这将包括测试一种能引起超免疫反应的金龟子分枝杆菌减毒株,以确定金龟子分枝杆菌是否可用于对蚊子进行疟原虫免疫。此外,我们将比较表达不同杀虫和抗疟原虫蛋白组合的绿僵菌菌株感染蚊子的死亡率和孢子虫流行率。将确定这些措施能否协同使用,以实现有效降低传播潜力。基于这些结果,我们还将测试利用绿僵菌表达合成多功能基因的效果,这些基因是不同活性的杂交,例如可以同时靶向昆虫和疟原虫。目前的建议是:1)探索蚊子的免疫系统;2)开发工具和基因工程真菌,这些工具和基因工程真菌有可能大大降低疟疾的患病率;3)开发僵菌作为一个可处理的模型系统,可用于筛选新的效应器。我们设想,经过筛选后,最有效的效应物可以通过在绿僵菌和/或替代病原体、共生体中表达或通过转基因蚊子传递给蚊子或疟原虫。本项目旨在设计、构建和评估针对成蚊和疟原虫的重组真菌病原体。产生一种优化的真菌病原体的最重要的可能结果将是由于阻断目标寄生虫的传播而减少人类疾病。
英文摘要
DESCRIPTION (provided by applicant): Around 46% of the World's population lives in areas where mosquito-borne diseases including malaria, filariasis, viral encephalitides, dengue and yellow fever are endemic. It was recently established that the insect pathogenic fungus Metarhizium anisopliae has the potential to control adult mosquitoes in an urban setting, but only if its potency is increased. Our goal is to produce one or more fungal products which can deplete anopheline and Plasmodium populations to the extent that marked reductions in malaria prevalence are achieved. We have already shown that M. anisopliae is a very effective delivery system for the insect-selective scorpion toxin AaIT, and that expressing AaIT produced a 9-fold reduction in effective spore doses against mosquitoes. This was very significant but kill times remain too slow for adequate protection. In this application, we propose experiments to compare several strategies for optimizing M. anisopliae's ability to curtail disease transmission. Mosquitoes infected with fungi showed a significant reduction in the number of sporozoites on salivary glands, but the mechanism responsible is unknown. We will carry out a detailed analysis of the interactions between Plasmodium, mosquitoes and M. anisopliae. This will include testing an attenuated strain of M. anisopliae that elicits a hyperimmune response to determine whether M. anisopliae can be used to immunize mosquitoes from Plasmodium. Further, we will compare mortality and sporozoite prevalence in mosquitoes infected with M. anisopliae strains expressing different combinations of insecticidal and anti-plasmodial proteins. It will be determined if these can be used synergistically to achieve effective reductions in transmission potential. Based on these results, we will also test the efficacy of using M. anisopliae to express synthetic multifunctional genes that are hybrids of different activities and that could, for example, target both the insect and the Plasmodium. The current proposal will: 1) explore the mosquito immune system; 2) develop tools and genetically engineered fungi that have the potential to greatly reduce malaria prevalence, and 3) develop M. anisopliae as a tractable model system that can be used to screen novel effectors. We envisage that after screening, the most potent effectors could be delivered against mosquitoes or Plasmodium by expression in M. anisopliae and/or in alternative pathogens, commensals or via transgenic mosquitoes. PUBLIC HEALTH RELEVANCE This project aims to design, construct and evaluate recombinant fungal pathogens that target adult mosquitoes and the malaria parasite. The most significant possible outcome of producing an optimized fungal pathogen will be a reduction of human disease as a result of interrupting transmission of the target parasite.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of Plasmodium fertilization
  • 批准号:
    9212860
  • 项目类别:
  • 资助金额:
    $40.8万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Molecular mechanisms of Plasmodium fertilization
  • 批准号:
    10064068
  • 项目类别:
  • 资助金额:
    $40.94万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccine
  • 批准号:
    9228326
  • 项目类别:
  • 资助金额:
    $24.3万
  • 财政年份:
    2016
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
Brain vascular dysfunction in cerebral malaria
  • 批准号:
    9281895
  • 项目类别:
  • 资助金额:
    $48.16万
  • 财政年份:
    2015
  • 负责人:
    MARCELO JACOBS-LORENA
  • 依托单位:
海外基金